Hon CHRIS HIPKINS: When we made the decision to switch to the predominantly Pfizer-led campaign, it did mean that our second-quarter vaccination numbers went down and our third- and fourth-quarter numbers went up based on the fact that some of the other vaccines that we were anticipating introducing earlier are no longer going to be introduced into the vaccination campaign.